irinotecan,sorafenib,atezolizumab,Bevacizumab,gemcitabine
ipsen,bayer,roche,
[]
day 2 #gi23 highlights #communityoncology 1. #source: adj tace+sorafenib in hcc (press release for #imbrave050) 2. #rtog1112: sbrt + sorafenib in hcc 3. #napoli3: liposomal irinotecan in 1l pancreatic cancer #onced #meded #oncology #gism
Practice changing #Oncology news from #CommunityOncologists perspective w/ Rohit Gosain @UPMCHillmanCC & Rahul Gosain @WilmotCancer. Views are our own.